BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19464537)

  • 1. Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients.
    Puissant-Lubrano B; Combadière B; Duffy D; Wincker N; Frachette MJ; Ait-Mohand H; Verrier B; Katlama C; Autran B
    Vaccine; 2009 Jun; 27(27):3576-83. PubMed ID: 19464537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.
    Combadiere B; Boissonnas A; Carcelain G; Lefranc E; Samri A; Bricaire F; Debre P; Autran B
    J Exp Med; 2004 Jun; 199(11):1585-93. PubMed ID: 15184506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
    Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R
    J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient in vitro anti-mycobacterial immunity despite successful long-term highly active antiretroviral therapy in HIV-infected patients with past history of tuberculosis infection or disease.
    Mendonça M; Tanji MM; Silva LC; Silveira GG; Oliveira SC; Duarte AJ; Benard G
    Clin Immunol; 2007 Oct; 125(1):60-6. PubMed ID: 17631053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells.
    Bourgarit A; Carcelain G; Samri A; Parizot C; Lafaurie M; Abgrall S; Delcey V; Vicaut E; Sereni D; Autran B;
    J Immunol; 2009 Sep; 183(6):3915-23. PubMed ID: 19726768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.
    Cagigi A; Nilsson A; De Milito A; Chiodi F
    Vaccine; 2008 Jun; 26(24):3016-25. PubMed ID: 18164520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].
    Bricaire F; Combadière B; Rouleau E; Bossi P; Garin D; Lebrun-Vignes B; Autran B
    Bull Acad Natl Med; 2006; 190(4-5):1035-46; discussion 1046-9. PubMed ID: 17195626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antigen-specific memory CD8+ T-cell response induced by BCG in cattle resides in the CD8+gamma/deltaTCR-CD45RO+ T-cell population.
    Hogg AE; Worth A; Beverley P; Howard CJ; Villarreal-Ramos B
    Vaccine; 2009 Jan; 27(2):270-9. PubMed ID: 18996428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculin specific T cell responses in BCG vaccinated children.
    Vijaya Lakshmi V; Kumar S; Surekha Rani H; Suman LG; Murthy KJ
    Indian Pediatr; 2005 Jan; 42(1):36-40. PubMed ID: 15695856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
    Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.
    Sirikwin S; Likanonsakul S; Waradejwinyoo S; Pattamadilok S; Kumperasart S; Chaovavanich A; Manatsathit S; Malerczyk C; Wasi C
    Vaccine; 2009 Jul; 27(32):4350-4. PubMed ID: 19487057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
    Thibault S; Imbeault M; Tardif MR; Tremblay MJ
    Virology; 2009 Jun; 389(1-2):20-5. PubMed ID: 19447460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
    Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
    J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
    Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
    Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of vaccination against hepatitis A in HIV infected adults from Lodz region--preliminary report].
    Jabłonowska E; Kuydowicz J; Małolepsza E
    Przegl Epidemiol; 2008; 62(3):605-12. PubMed ID: 19108525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.